Clinical Trial Status Report
This is a practical guide to building a status report for a clinical trial project — a periodic summary of progress, issues and next steps, adapted to the realities of planning and running a clinical trial.
What a Status Report is
A status report is a periodic summary of progress, issues and next steps. For the full concept and how it works in general, see Status Report. On a clinical trial project it plays the same role, tuned to this kind of work.
Why it matters for a Clinical Trial project
Clinical Trial projects live or die on planning and running a clinical trial. A well-built status report gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how clinical trial projects drift into avoidable delay and cost.
What to include
- Overall RAG status
- Progress vs plan
- Key risks and issues
- Budget/schedule health
- Decisions needed
Clinical Trial-specific considerations
Tailor the status report to the risks that most often derail clinical trial projects:
- Regulatory and ethics approval
- Patient recruitment
- Data integrity
Example
On a real clinical trial project, the status report would be shaped by planning and running a clinical trial. In particular, it should explicitly account for the project’s biggest risks — regulatory and ethics approval, patient recruitment, data integrity — rather than treating them as afterthoughts.